Zentiva Sees Success With Apontis Buyout
Captures Just Over 85% Of Voting Rights After Voluntary Public Purchase Offer
Zentiva is moving ahead with its takeover of Apontis Pharma after its voluntary public purchase offer resulted in it securing almost 84% of share capital and a more than 85% share of voting rights.
